Hint mode is switched on Switch off

LAVA Therapeutics, ordinary share
LVTX, NL0015000AG6

FIND, SAVE & TRACK INVESTMENTS WITH CBONDS WATCHLIST

With Cbonds Watchlist you can always stay updated on your investments to make conscious decisions!

Watchlist
You need to request access
Add a stock to WL
Choose all Reset all
LAVA Therapeutics, сountry — Netherlands
No trading data
Data display in a chart | table
Source of information - PJSC "MOEX". Further disctribution of MOEX information is prohibited without prior consent with PJSC "MOEX".
Source of information - PJSC "MOEX". Further disctribution of MOEX information is prohibited without prior consent with PJSC "MOEX".
No data
from
to
ADD-IN
Cbonds add-in API
bond data api
Authorization required
You need to request access
More than 2,500 records have been found, please specify your request
No data for the selected period
Welcome to Cbonds
New to Cbonds? · Take a 90-second tour of the platform.

Discover what you can do with Cbonds

Everything you need for fixed income research and monitoring.

  • 00:23 Coverage
  • 00:40 Bond screener
  • 00:54 Parameters
  • 01:10 Watchlist, Mobile app
  • 01:15 Excel Add-in
Unlock data Watch full tour

Latest quotes

Get access to the largest financial database

Try in 7-days Demo access

Free for company representative

  • Evaluate advanced analytical tools
  • Get full online access to the database
  • Try our powerful bond screener
  • Track bond prices from 400+ sources

Get access to the largest financial database

Representative of the company 7 days FREE trial

Professional access to the data

Private investor

Individual access

Issuer

Profile
LAVA Therapeutics NV is a biotechnology company. It is focused on transforming cancer treatment by developing a platform of novel bispecific antibodies designed to selectively induce gamma-delta T cell-mediated immunity against tumor cells.
  • Issuer
  • Full borrower / issuer name
    LAVA Therapeutics NV
  • Industry
    Pharmaceutical Preparation and Biotechnology

Placement data

  • Placement type
    IPO | Finished
  • Subscription type
    Open
  • Placement exchange
    NASDAQ
  • Ticker
    LVTX
  • Placement
    25.03.2021
  • Lock up period
    180
  • Number of papers
    6,700,000
  • Volume of raised funds
    100.5 mln USD
  • Placement share
    26.43%
  • Final placement price
    15 USD
  • Price change since placement date
    -100%
  • By capitalization
    380.28 mln USD

IFRS/US GAAP reports

2025
I q eng
II q eng
2024
IV q eng
2023
IV q eng
2022
IV q eng
2021
IV q eng
Show more Hide

Indicators

News

21/11/2025 LAVA Therapeutics: Completion Of Acquisition Or Disposition Of Assets, Notice Of Delisting Or Failure To Satisfy A Continued Listing Ruleor Standard; Transfer Of Listing, Material Modification To Rights Of Security Holders, Departure Of Directors Or Certain Officers; Election Of Directors; Appointment Of Certain Officers; Compensatory Arrangements Of Certain Officers
12/11/2025 LAVA Therapeutics: Notice Of Delisting Or Failure To Satisfy A Continued Listing Rule Or Standard; Transfer Of Listing, Changes In Control Of Registrant, Departure Of Directors Or Certain Officers; Election Of Directors; Appointment Of Certain Officers; Compensatory Arrangements Of Certain Officers, Financial Statements And Exhibits
17/10/2025 LAVA Therapeutics: Entry Into A Material Definitive Agreement, Other Events, Financial Statements And Exhibits
30/09/2025 LAVA Therapeutics: Other Events, Financial Statements And Exhibits
13/08/2025 LAVA Therapeutics: Regulation Fd Disclosure, Other Information, Financial Statements And Exhibits
All organization news

Holders

Industry Leaders

Registration is required to get access.